Vermont
Vermont
In the development of new medicines, clinical trials are conducted to prove therapeutic safety and effectiveness and compile the evidence needed for the Food and Drug Administration (FDA) to approve treatments. And the biopharmaceutical sector is committed to bringing new treatments and cures to patients. This commitment to innovation supports high-quality jobs and is a vital part of every state’s economy and our global economic competitiveness.
In Your State
Economic Impact In Your State: Vermont
Economic Impact
$1.8B
Total output supported by biopharmaceutical sector
$104.2M
Tax Revenue Generated
6,050
Total Jobs
1,339
Direct Jobs
91
Total Clinical Trials
$12.2 million
Invested in Clinical Trials
1106
Total Economic Impact of Clinical Trial Investments
$30 million
Invested in Clinical Trials
Programs and Initiatives in Your State: Vermont
State programs and initiatives to promote biopharmaceutical industry development
- Accelerating Innovation, Commercialization & Entrepreneurial Development
- Economic Innovation Incentives
- Venture Financing
Programs and Initiatives
Related Resources
Research in Your Backyard
Fact Sheet